Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
therapeutics entities : Pfizer, inc. save search
Serina Therapeutics Announces Completion of Merger with AgeX Therapeutics
Published: 2024-03-26 (Crawled : 21:00) - globenewswire.com
PFE | News 4 | $26.27 -0.19% -0.15% 23M
|
Health Technology
|
| O: 0.43%
H: 0.81%
C: 0.25%
therapeutics
Alkermes Announces Appointment of Nancy S. Lurker to Board of Directors
Published: 2024-03-07 (Crawled : 12:00) - prnewswire.com
PFE | News 4 | $26.27 -0.19% -0.15% 23M
|
Health Technology
|
| O: 0.04%
H: 0.44%
C: -1.51%
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: -2.08%
H: 0.13%
C: -0.57%
BMY | $48.86 -0.27% -0.02% 16M
|
Health Technology
|
| O: 0.36%
H: 0.34%
C: -0.54%
XFOR | $1.28 4.06% 3.91% 2.2M
|
Health Technology
|
| O: 0.12%
H: 0.0%
C: -4.98%
EYPT | News | $16.47 -6.26% -6.68% 1.1M
|
Health Technology
|
| O: 2.56%
H: 1.37%
C: -4.13%
AQST | $3.905 -8.76% -9.6% 2.1M
|
Health Technology
|
| O: 1.79%
H: 12.3%
C: 10.94%
ALKS | $24.66 1.65% 1.62% 1.7M
|
Health Technology
|
| O: 1.11%
H: 0.96%
C: 0.65%
BlossomHill Therapeutics Chief Executive Officer, Jingrong Jean Cui, Ph.D., Elected to the National Academy of Engineering
Published: 2024-02-14 (Crawled : 14:00) - biospace.com/
PFE | News 4 | $26.27 -0.19% -0.15% 23M
|
Health Technology
|
| O: 0.15%
H: 0.59%
C: 0.37%
therapeutics
Carrick Therapeutics Announces First Patient Dosed in Phase 1b/2 Clinical Trial of Samuraciclib in Combination with Vepdegestrant in Patients with Advanced Breast Cancer
Published: 2024-02-14 (Crawled : 14:00) - biospace.com/
PFE | News 4 | $26.27 -0.19% -0.15% 23M
|
Health Technology
|
| O: 0.15%
H: 0.59%
C: 0.37%
ARVN | $32.51 -4.38% -4.58% 470K
|
Health Technology
|
| O: -1.09%
H: 5.61%
C: 4.49%
first breast cancer trial therapeutics advanced
Global CAR T-Cell Therapy Market Analysis Report 2023: Drug type, Indication, Target Antigen, End-user and Region - Forecast to 2030
Published: 2024-01-24 (Crawled : 17:00) - prnewswire.com
PFE | News 4 | $26.27 -0.19% -0.15% 23M
|
Health Technology
|
| O: 0.39%
H: 0.82%
C: -0.74%
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: 0.22%
H: 0.43%
C: -0.39%
SRNE | $0.015 -8.85% 56K
|
Health Technology
|
| O: -63.33%
H: 263.64%
C: 127.27%
GILD | $67.07 0.06% 0.06% 8.3M
|
Health Technology
|
| O: 0.1%
H: 0.43%
C: -0.04%
AUTL | $4.23 -5.58% -5.91% 2.7M
|
Health Technology
|
| O: -0.91%
H: 11.52%
C: 4.94%
drug report t-cell global therapy market
Global Vaginitis Therapeutics Market Size Projected to Reach USD 7.20 Billion By 2032, With 8.1% CAGR Growth: Polaris Market Research
Published: 2023-11-23 (Crawled : 15:30) - prnewswire.com
PFE | News 4 | $26.27 -0.19% -0.15% 23M
|
Health Technology
| Email alert
Add to watchlist
NVSEF | News | $96.0 6.88% 52K
|
Health Technology
| Email alert
Add to watchlist
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
| Email alert
Add to watchlist
reach research global therapeutics market
Anti-inflammatory Therapeutics Market Size to Hit US$ 149.5 billion by 2031 | Exclusive Study by Transparency Market Research
Published: 2023-10-30 (Crawled : 09:00) - prnewswire.com
GLAXF | News | $19.54 -14.18% 2.6K
|
Health Technology
|
| O: -4.67%
H: 4.9%
C: 4.9%
SNYNF | News | $94.25 -2.18% 480
|
Health Technology
|
| O: 2.76%
H: 0.0%
C: 0.0%
PFE | News 4 | $26.27 -0.19% -0.15% 23M
|
Health Technology
|
| O: 0.43%
H: 1.46%
C: 1.03%
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: 1.69%
H: 0.25%
C: -0.07%
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: -1.39%
H: 0.79%
C: 0.64%
GSK | News | $40.86 -0.92% -0.15% 1.7M
|
Health Technology
|
| O: 2.29%
H: 0.44%
C: -0.23%
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
|
| O: 2.87%
H: 0.0%
C: 0.0%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: -0.85%
H: 0.0%
C: 0.0%
research therapeutics study market
Everest Medicines Announces Poster Presentation at ASN Kidney Week on Nefecon® Chinese Patient Data and to Hold Conference Calls
Published: 2023-10-27 (Crawled : 01:00) - prnewswire.com
PFE | News 4 | $26.27 -0.19% -0.15% 23M
|
Health Technology
|
| O: -0.32%
H: 0.23%
C: -3.06%
CALT | $18.5 1.65% 1.62% 1.5K
|
Health Technology
|
| O: 2.58%
H: 0.08%
C: -3.42%
nefecon conference kidney presentation chinese week
Rising R&D Investment and Government Support Fuel Expansion of Global Duchenne Muscular Dystrophy Drugs Market
Published: 2023-10-24 (Crawled : 23:00) - prnewswire.com
PFE | News 4 | $26.27 -0.19% -0.15% 23M
|
Health Technology
|
| O: 0.1%
H: 1.77%
C: 0.89%
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: 2.75%
H: 0.46%
C: -1.76%
BMY | $48.86 -0.27% -0.02% 16M
|
Health Technology
|
| O: -0.18%
H: 1.34%
C: 1.05%
PTCT | News S | $25.19 -0.87% -0.87% 560K
|
Health Technology
|
| O: -1.34%
H: 2.23%
C: 1.62%
LXRX | $1.6 -0.62% -0.63% 1.8M
|
Health Technology
|
| O: -1.68%
H: 0.85%
C: -2.99%
expansion global duchenne market
CRISPR Therapeutics Proposes New Appointment to the Board of Directors
Published: 2023-10-16 (Crawled : 12:00) - globenewswire.com
PFE | News 4 | $26.27 -0.19% -0.15% 23M
|
Health Technology
|
| O: 2.24%
H: 3.32%
C: 1.34%
SRPT | $124.27 6.11% 5.75% 1.3M
|
Health Technology
|
| O: -0.18%
H: 1.11%
C: -0.17%
CRSP | News 4 | $55.66 -1.33% -1.35% 910K
|
Health Technology
|
| O: 0.0%
H: 1.67%
C: 1.13%
crispr therapeutics
Everest Medicines' Licensing Partner Pfizer Announces U.S. FDA Approves Etrasimod for Adults with Moderately to Severely Active Ulcerative Colitis
Published: 2023-10-15 (Crawled : 00:00) - prnewswire.com
PFE | News 4 | $26.27 -0.19% -0.15% 23M
|
Health Technology
|
| O: 2.24%
H: 3.32%
C: 1.34%
CALT | $18.5 1.65% 1.62% 1.5K
|
Health Technology
|
| O: 2.19%
H: 1.47%
C: -3.78%
fda active
Global Vulvovaginal Candidiasis Treatment Market Research Report 2023-2028 - Demand for Cost-effective Vulvovaginal Candidiasis Treatment Soars with Growing Geriatric Population
Published: 2023-10-04 (Crawled : 23:00) - prnewswire.com
ALPMY | News | $9.49 -1.11% 480K
|
Manufacturing
|
| O: 0.59%
H: 0.29%
C: 0.22%
PFE | News 4 | $26.27 -0.19% -0.15% 23M
|
Health Technology
|
| O: 0.42%
H: 0.99%
C: 0.06%
SCYX | $1.495 -3.55% -3.68% 88K
|
Health Technology
|
| O: 0.45%
H: 4.04%
C: 0.45%
CDTX | News | $11.94 16.49% 14.15% 170K
|
Health Technology
|
| O: 0.39%
H: 10.33%
C: 3.9%
report treatment candidiasis research global growing market
RNA Therapeutics Market worth $18.0 billion | MarketsandMarkets
Published: 2023-09-15 (Crawled : 15:00) - prnewswire.com
SNYNF | News | $94.25 -2.18% 480
|
Health Technology
|
| O: 1.53%
H: 0.0%
C: 0.0%
NVSEF | News | $96.0 6.88% 52K
|
Health Technology
|
| O: 0.79%
H: 0.0%
C: 0.0%
ALPMY | News | $9.49 -1.11% 480K
|
Manufacturing
|
| O: 3.0%
H: 0.0%
C: -3.43%
PFE | News 4 | $26.27 -0.19% -0.15% 23M
|
Health Technology
|
| O: -0.26%
H: 1.04%
C: 0.03%
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: 1.51%
H: 0.26%
C: -0.72%
SRPT | $124.27 6.11% 5.75% 1.3M
|
Health Technology
|
| O: -0.27%
H: 0.54%
C: -0.84%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 0.82%
H: 0.0%
C: 0.0%
MRNA | News S | $108.82 0.86% 0.85% 3.4M
|
Health Technology
|
| O: 0.16%
H: 2.0%
C: 1.42%
IONS | $42.455 1.47% 1.45% 730K
|
Health Technology
|
| O: -0.57%
H: 0.35%
C: -1.11%
BNTX | News | $88.18 -0.35% -0.35% 280K
|
Health Technology
|
| O: 0.17%
H: 0.48%
C: -0.82%
ARWR | $23.285 -2.08% -2.13% 810K
|
Health Technology
|
| O: 0.16%
H: 0.46%
C: -5.46%
ALNY | $143.8 -1.55% -1.58% 390K
|
Health Technology
|
| O: -0.74%
H: 2.42%
C: -3.47%
therapeutics market
Everest Medicines Announces Interim Results for First Half of 2023
Published: 2023-08-24 (Crawled : 01:00) - prnewswire.com
PFE | News 4 | $26.27 -0.19% -0.15% 23M
|
Health Technology
|
| O: -0.5%
H: 0.45%
C: -0.86%
GILD | $67.07 0.06% 0.06% 8.3M
|
Health Technology
|
| O: 0.27%
H: 1.15%
C: -1.19%
CALT | $18.5 1.65% 1.62% 1.5K
|
Health Technology
|
| O: -4.72%
H: 0.0%
C: 0.0%
results
TFC Therapeutics Launches to Advance Novel Platform and Technologies in Cancer Biology
Published: 2023-08-17 (Crawled : 17:00) - biospace.com/
PFE | News 4 | $26.27 -0.19% -0.15% 23M
|
Health Technology
|
| O: 0.34%
H: 3.15%
C: 2.56%
cancer therapeutics platform
Carrick Therapeutics Announces Clinical Trial Collaboration with Arvinas and Pfizer to Evaluate Samuraciclib and Vepdegestrant Combination
Published: 2023-07-06 (Crawled : 14:00) - biospace.com/
PFE | News 4 | $26.27 -0.19% -0.15% 23M
|
Health Technology
|
| O: -0.71%
H: 0.19%
C: -1.57%
ARVN | $32.51 -4.38% -4.58% 470K
|
Health Technology
|
| O: -2.06%
H: 0.0%
C: -3.96%
collaboration trial therapeutics
Global CNS Therapeutics Strategic Business Report 2023: Burgeoning Global Aging Populace, Longer Life Expectancy to Drive CNS Demand
Published: 2023-06-30 (Crawled : 23:00) - prnewswire.com
ALKS | $24.66 1.65% 1.62% 1.7M
|
Health Technology
| Email alert
Add to watchlist
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
| Email alert
Add to watchlist
NBIX | News 4 | $138.91 -0.84% -0.85% 880K
|
Health Technology
| Email alert
Add to watchlist
SNYNF | News | $94.25 -2.18% 480
|
Health Technology
| Email alert
Add to watchlist
UCBJY | $65.26 -4.38% 5.9K
|
Manufacturing
| Email alert
Add to watchlist
UCBJF | $128.725 -39.66% 750
|
Health Technology
| Email alert
Add to watchlist
AZNCF | News | $140.3 -4.19% 1.5K
|
Health Technology
| Email alert
Add to watchlist
PFE | News 4 | $26.27 -0.19% -0.15% 23M
|
Health Technology
| Email alert
Add to watchlist
TAK | News | $13.23 -1.12% 0.0% 920K
|
Health Technology
| Email alert
Add to watchlist
NVSEF | News | $96.0 6.88% 52K
|
Health Technology
| Email alert
Add to watchlist
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
| Email alert
Add to watchlist
BMY | $48.86 -0.27% -0.02% 16M
|
Health Technology
| Email alert
Add to watchlist
AZN | News | $71.175 0.46% 0.46% 6.1M
|
Health Technology
| Email alert
Add to watchlist
TEVJF | News | $12.37 -24.22% 380
|
Health Technology
| Email alert
Add to watchlist
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
| Email alert
Add to watchlist
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
| Email alert
Add to watchlist
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
| Email alert
Add to watchlist
report business life global therapeutics
Spero Therapeutics Appoints Sath Shukla as President & Chief Executive Officer
Published: 2023-06-14 (Crawled : 12:00) - globenewswire.com
PFE | News 4 | $26.27 -0.19% -0.15% 23M
|
Health Technology
|
| O: 0.1%
H: 0.05%
C: -2.38%
GSK | News | $40.86 -0.92% -0.15% 1.7M
|
Health Technology
|
| O: 0.29%
H: 0.09%
C: -0.78%
SPRO | $1.41 -1.74% -1.77% 110K
|
Health Technology
|
| O: 0.0%
H: 0.58%
C: -5.81%
therapeutics
Peptide Therapeutics Global Market Report 2023: Increase in the Prevalence of Chronic Diseases Drives Growth
Published: 2023-06-01 (Crawled : 22:00) - prnewswire.com
SNYNF | News | $94.25 -2.18% 480
|
Health Technology
|
| O: -0.56%
H: 0.0%
C: 0.0%
AZNCF | News | $140.3 -4.19% 1.5K
|
Health Technology
|
| O: -0.74%
H: 1.4%
C: 0.35%
NVSEF | News | $96.0 6.88% 52K
|
Health Technology
|
| O: 0.99%
H: 0.0%
C: 0.0%
TAK | News | $13.23 -1.12% 0.0% 920K
|
Health Technology
|
| O: 1.32%
H: 0.31%
C: 0.12%
PFE | News 4 | $26.27 -0.19% -0.15% 23M
|
Health Technology
|
| O: 0.6%
H: 1.07%
C: 0.29%
NVO | News | $126.16 -1.93% -0.23% 3.1M
|
Health Technology
|
| O: -1.84%
H: 1.62%
C: 1.33%
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: 1.03%
H: 0.84%
C: 0.82%
BMY | $48.86 -0.27% -0.02% 16M
|
Health Technology
|
| O: 0.37%
H: 1.34%
C: 1.14%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 1.05%
H: 0.0%
C: 0.0%
AZN | News | $71.175 0.46% 0.46% 6.1M
|
Health Technology
|
| O: 0.11%
H: 0.69%
C: -0.45%
report global therapeutics growth market
Duchenne Muscular Dystrophy Drugs Global Market Report 2023: Sector to Reach $18.1 Billion by 2030 at a 42.5% CAGR
Published: 2023-05-03 (Crawled : 18:00) - prnewswire.com
PFE | News 4 | $26.27 -0.19% -0.15% 23M
|
Health Technology
|
| O: -0.73%
H: 0.68%
C: 0.16%
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: 0.06%
H: 0.29%
C: -0.7%
BMY | $48.86 -0.27% -0.02% 16M
|
Health Technology
|
| O: -0.29%
H: 1.19%
C: 0.56%
PTCT | News S | $25.19 -0.87% -0.87% 560K
|
Health Technology
|
| O: -0.38%
H: 1.38%
C: 1.2%
LXRX | $1.6 -0.62% -0.63% 1.8M
|
Health Technology
|
| O: 2.19%
H: 13.21%
C: 10.0%
report reach global duchenne market
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.